Fig. 3From: Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trialCRP-Hs levels after 24 weeks of treatment. = AP, = PL Treatment. * = p < 0.05 24 wks vs BaselineBack to article page